Xarelto Lawsuit News: New Xarelto Settlement Update

September 29, 2015 – – BloodThinnerHelp.com reports today on the latest news about Xarelto lawsuit settlements. Although at this point in time no settlements have been made, initial trial dates have been announced and the litigation is moving forward. For more detailed information about the Xarelto lawsuits, click here.

The lawsuits that are filed in the Xarelto multidistrict litigation, MDL, all make similar allegations against the manufacturers of Xarelto, Bayer AG and Janssen Pharmaceuticals, including that the drug can cause severe uncontrollable internal bleeding and that the manufacturers were aware of the dangers of Xarelto and failed to adequately warn doctors and patients about them. Because the cases against Xarelto are filed as individual personal injury lawsuits, it is very difficult to say how much these cases will settle for since the circumstances of each case are very different.

Initial Xarelto Trials Announced:

Although there have been no settlements on the Xarelto litigation yet, the dates for the bellwether trials have been set. The Xarelto trials will begin on February 6, 2017 in the Eastern District of Louisiana. A second trial will take place in the same district on March 13, 2017, a third trial will occur in Mississippi on April 24, 2017, and a fourth will be held in Texas on May 30, 2017.

The lawsuits filed all contain different types of damages, some economic and some non-economic. Economic damages consist of medical expenses, long term and future medical care, loss of earnings, loss of future income, and funeral and burial expenses. Non-economic damages consist of compensation for pain and suffering and for loss of companionship. Each case will have varying amounts of these damages listed, which is what makes estimating a settlement very difficult.

To make a rough estimate, we can look to a case in recent history that is similar to Xarelto. In May 2014 Pradaxa, a blood thinner that is similar to Xarelto, settled cases that were similar in nature to the Xarelto litigation that is currently unfolding. Pradaxa’s manufacturers, Boehringer Ingelheim, settled 4,000 lawsuits against their blood thinner for $650 million dollars.

“We are still unsure how the Xarelto litigation will play out, but we are dedicated to bringing Xarelto victims justice.” Xarelto attorney Marc Goldich said, “We strongly encourage anybody who has been harmed by Xarelto to contact us immediately.”

For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

ReleaseID: 60004454